presented by Dr. rer. nat. Maria Steinke, UK Würzburg, Klinik und Poliklinik für HNO-Krankheiten, plastische und ästhetische Operationen und Fraunhofer-Institut für Silicatforschung ISC, Translationszentrum für Regenerative Therapien, Würzburg Nasal xenobiotic metabolizing enzymes (XMEs) are important Weiterlesen…
presented by Prof. Dr. Gerhard Gstraunthaler, emer. Medizinische Universität Innsbruck Instances of cross-contamination of cell lines are more widespread than generally appreciated. Despite periodic reminders from concerned cell culturists, the problem continues and even seems Weiterlesen…
presented by Dr. Jieun An, Nexel Co., Ltd., Republic of Korea Cardiac toxicity is a major cause of compound attrition during drug development as well as for the withdrawal of drugs already on the market. Weiterlesen…
presented by Prof. Dr. Sehyun Shin, Korea University & CEO, Microgentas Inc., Seoul, Korea This webinar will showcase Microgentas‘ innovative approaches for scalable EV isolation and high-quality purification, focusing on the integration of charge-based filtration Weiterlesen…
presented by Dr. Kurt Pfannkuche, Universität zu Köln Induced pluripotent stem cells (iPSCs) can be differentiated into heart muscle cells in vitro and open up new possibilities for the development of therapies for myocardial infarction. Weiterlesen…
Our conference „Advancements in Animal-Free Research and Translational Medicine“ will promote novel non-animal approaches that are essential for progress in translational medical research. The focus will be on the development and validation of serum substitutes, Weiterlesen…
